Cite

HARVARD Citation

    Coles, A. et al. (2021). Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial. Therapeutic advances in neurological disorders. p. . [Online]. 
  
Back to record